Literature DB >> 15507530

BCL-6 negatively regulates macrophage proliferation by suppressing autocrine IL-6 production.

Raymond Yick-Loi Yu1, Xing Wang, Fiona J Pixley, J Jessica Yu, Alexander L Dent, Hal E Broxmeyer, E Richard Stanley, B Hilda Ye.   

Abstract

The transcription repressor BCL-6 is known to play critical roles in B-cell lymphomagenesis, germinal center formation, and balanced Th1/Th2 differentiation. In macrophages, although BCL-6 has also been shown to regulate the expression of several chemokine genes, its function in other aspects of macrophage biology has not been studied. In addition, the precise role of BCL-6 in cell proliferation is poorly understood in general. Here we report that BCL-6(-/-) macrophages hyperproliferate due to an accelerated G(1)/S transition accompanied by increased cyclin D2 and c-myc and decreased expression of p27. Crucial to this enhanced proliferation is spontaneous interleukin 6 (IL-6) production and signal transducer and activator of transcription 3 (STAT3) activation in BCL-6(-/-) macrophages. In colony-forming assays, BCL- 6(-/-) bone marrow progenitor cells form spontaneous macrophage colonies that can be inhibited by anti-IL-6 antibodies. Gene expression studies demonstrate that BCL-6 binds to several sequence motifs scattered in the IL-6 locus and can repress IL-6 transcription both in 293T cells and in macrophages. In conclusion, our results indicate that BCL-6 negatively regulates proliferation of the monocytic/macrophage lineage by suppressing an autocrine IL-6/STAT3-mediated gene expression program. Our work also suggests that BCL-6 prevents abnormal Th2 differentiation by suppressing basal level IL-6 production in antigen-presenting cells (APCs).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507530     DOI: 10.1182/blood-2004-08-3171

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas.

Authors:  B Belinda Ding; J Jessica Yu; Raymond Y-L Yu; Lourdes M Mendez; Rita Shaknovich; Yonghui Zhang; Giorgio Cattoretti; B Hilda Ye
Journal:  Blood       Date:  2007-10-19       Impact factor: 22.113

2.  Endometrial BCL6 testing for the prediction of in vitro fertilization outcomes: a cohort study.

Authors:  Laura D Almquist; Creighton E Likes; Benjamin Stone; Kaitlin R Brown; Ricardo Savaris; David A Forstein; Paul B Miller; Bruce A Lessey
Journal:  Fertil Steril       Date:  2017-11-07       Impact factor: 7.329

3.  miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model.

Authors:  Sukhinder K Sandhu; Stefano Volinia; Stefan Costinean; Marco Galasso; Reid Neinast; Ramasamy Santhanam; Mark R Parthun; Danilo Perrotti; Guido Marcucci; Ramiro Garzon; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

Review 4.  The BTB-ZF transcription factors.

Authors:  Owen M Siggs; Bruce Beutler
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

5.  Evaluation of in vitro macrophage differentiation during space flight.

Authors:  M Teresa Ortega; Nanyan Lu; Stephen K Chapes
Journal:  Adv Space Res       Date:  2012-02-27       Impact factor: 2.152

6.  RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.

Authors:  William O'Brien; Brian M Fissel; Yukiko Maeda; Jing Yan; Xianpeng Ge; Ellen M Gravallese; Antonios O Aliprantis; Julia F Charles
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

7.  Modulation of inflammatory gene expression by the ribotoxin deoxynivalenol involves coordinate regulation of the transcriptome and translatome.

Authors:  Kaiyu He; Xiao Pan; Hui-Ren Zhou; James J Pestka
Journal:  Toxicol Sci       Date:  2012-09-11       Impact factor: 4.849

8.  CtBP is an essential corepressor for BCL6 autoregulation.

Authors:  Lourdes M Mendez; Jose M Polo; J Jessica Yu; Melissa Krupski; B Belinda Ding; Ari Melnick; B Hilda Ye
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

9.  BCL6 controls Th9 cell development by repressing Il9 transcription.

Authors:  Ribal Bassil; William Orent; Marta Olah; Ahmed T Kurdi; Michael Frangieh; Thomas Buttrick; Samia J Khoury; Wassim Elyaman
Journal:  J Immunol       Date:  2014-05-30       Impact factor: 5.422

10.  Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma.

Authors:  Daniel Beck; Jenny Zobel; Ruth Barber; Sian Evans; Larissa Lezina; Rebecca L Allchin; Matthew Blades; Richard Elliott; Christopher J Lord; Alan Ashworth; Andrew C G Porter; Simon D Wagner
Journal:  J Biol Chem       Date:  2016-06-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.